首页> 外文OA文献 >Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease
【2h】

Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease

机译:评价AGR2和AGR3作为炎症性肠病的候选基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Linkage analyses have implicated chromosome 7p21.3 as a susceptibility region for inflammatory bowel disease (IBD). Recently, the mouse phenotype with diarrhea and goblet cell dysfunction caused by anterior gradient protein 2 dysfunction was reported ( European patent WO2004056858). The genes encoding for the human homologues AGR2 and AGR3 are localized on chromosome 7p21.3. The gene structures were verified and mutation detection was performed in 47 IBD patients. A total of 30 single nucleotide polymorphisms ( SNPs) were tested for association to ulcerative colitis ( UC, N = 317) and Crohn's disease ( CD, N 631) in a German cohort and verified in a UK cohort of 384 CD and 311 UC patients. An association signal was identified in the 50 region of the AGR2 gene ( most significant SNP hcv1702494, nominal P-TDT = 0.011, P-case/control = 0.0007, OR = 1.34, combined cohort). The risk haplotype carried an odds ratio of 1.43 in the German population ( P = 0.002). AGR2 was downregulated in UC patients as compared to normal controls ( P <0.001) and a trend toward lower expression was seen in carriers of the risk alleles. Luciferase assays of the AGR2 promoter showed regulation by the goblet cell-specific transcription factors FOXA1 and FOXA2. In summary, AGR2 represents an interesting new avenue into the etiopathophysiology of IBD and the maintenance of epithelial integrity
机译:连锁分析表明染色体7p21.3是炎症性肠病(IBD)的易感区域。最近,报道了具有由前梯度蛋白2功能障碍引起的腹泻和杯状细胞功能障碍的小鼠表型(欧洲专利WO2004056858)。编码人类同源物AGR2和AGR3的基因位于染色体7p21.3。验证了基因结构,并对47名IBD患者进行了突变检测。在德国队列中测试了总共30个单核苷酸多态性(SNP)与溃疡性结肠炎(UC,N = 317)和克罗恩病(CD,N 631)的关联,并在384名CD和311名UC患者的英国队列中进行了验证。在AGR2基因的50个区域(最高SNP hcv1702494,标称P-TDT = 0.011,P-case / control = 0.0007,OR = 1.34,组合队列)中鉴定到关联信号。风险单倍型在德国人口中的比值比为1.43(P = 0.002)。与正常对照组相比,UC患者的AGR2被下调(P <0.001),并且在风险等位基因携带者中发现了表达降低的趋势。 AGR2启动子的萤光素酶检测显示受杯状细胞特异性转录因子FOXA1和FOXA2的调节。总而言之,AGR2代表了IBD的病因生理学和维持上皮完整性的有趣新途径

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号